NutrEvent 2017 – Preliminary conference programme
The NutrEvent conference programme is designed to combine research innovation and market access and aims to develop the existing bridges built between the sectors involved.
The complexity of this constantly evolving market and increasing consumer needs requires these sectors to work together to propose adapted offers. The NutrEvent conference programme proposes to explore how to combine expertise, how to ensure the success of cross-sectorial collaborations and translational research and how to adapt to current market trends.
Innovation in 2017 will come from exchanging about evolving customer needs and research results and the resulting collaborative research and cross-sectorial collaborations. Organised around three tracks, panels will discuss the latest innovations in functional and active ingredients, market regulatory changes, traceability enhancement and food safety improvement. The additional benefits for both researchers and the industry of collaborating at every stage of development, from bench to market through cross-sector projects, will also be discussed.
PLENARY SESSION – What are the drivers for tomorrow’s innovation in Nutrition, Food and Health?
- Which innovations will shape the future of the sector?
- What are the market opportunities associated with these innovations?
- What is the role of the consumer in the industry’s evolution?
TRACK 1 – Sourcing innovation
This track will focus on how academic research is translated into innovation and how innovation can improve consumer health and prevent disease.
With microbiota as its focus, the sessions will highlight successful academic/industry collaborations and discuss cohort study results, functional ingredient development, new excipients and their properties in addition to the latest advances in processing and food safety.
- What are the clearly linked benefits between microbiota and biomarkers?
- What does this mean for research and collaborations?
- The advantages of new transformation processes (such as limit microbiota alteration through decreasing oligoelements influence)
- New technologies in clean processes are opening doors to industry collaborations
- Case studies of recent collaborative success stories:
- Finished goods/ingredient producers
- Biotech/nutrition partnerships
- Food/feed alliances which benefit innovation
- Addresses new applications of functional ingredients:
- To boost disease prevention (such as diabetes prevention)
- To improve health world-wide (oral applications)
TRACK 2 – Funding innovation
This track will focus on the road from innovation to market and the challenges and opportunities along the way.
Consumer market trends, regulatory evolutions, incremental innovations in ingredients and finding the right financing for innovation projects are just some of the topics to be covered.
TRACK 3 – Marketing innovation
This track will encourage debate about trending topics such as cross sectorial collaborations and the challenges encountered and case studies of successful projects.
Examples of discussions will include:
- Can the hard lessons learned from one field be transmitted to another for the benefit of all?
- Is the application of pharma clinical trials to nutrition a “false” good idea?
- Can active ingredients boost drug effects?
- How are the food and feed sectors collaborating on the development of new probiotics?
- Can Big Data lead to cross-sectorial projects?
- Understanding the market and consumer expectations
- Making the difference between well-being and medical needs
- How does the health claims landscape serve incremental innovation rather than radical innovation and new product development?
- Is the industry overusing claims and regulations as a pretext in healthy food marketing?
- What are the consequences of regulatory constraints on nutrigenomic ethics?
- How education, consumer behavior and genetics affect early life?
- How can we create a better, healthier, more personalized diet for mothers?
- The first 1000 days: Changing dietary behaviour
- What do probiotics in the infant formula segment represent?
- Health issues, innovation and the regulatory landscape - Challenges and opportunities
- What opportunity do the Chinese, African and Indian markets represent?
- What have we learnt from the evolution of the European market to predict Asian and African market patterns?